Previous 10 | Next 10 |
ABINGDON, OXFORDSHIRE ACCESSWIRE / June, 17, 2020 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines announces that options over a total of 1,401,000 ordinary shares of 0.1 pence each in t...
Preliminary results for the year ended 31 December 2019 ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 16, 2020 / Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines announces its audited p...
This Announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. Upon the publication of this Announcement, this inside information is now considered to be in the public domain. ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 9, 2020 / Midatech Pharma PLC...
Correction: The following amendment has been made to the 'UK Placing to Raise £1.8 million' announcement released on 18 May 2020. The following text should have read: 'The Combined Proceeds, net of fees and expenses are expected to be approximately £3.8 million ("Aggregate ...
Gainers: Oasis Midstream Partners (NASDAQ: OMP ) +79% . More news on: Oasis Midstream Partners LP, Aurora Cannabis Inc., Marine Petroleum Trust, Stocks on the move, , Read more ...
Midatech Pharma ( MTP -36.5% ) has entered into definitive agreements with institutional investors for the purchase in a registered direct offering of ~1.82M ADS at a purchase price of $1.65/ADS, for aggregate gross proceeds of $3M. More news on: Midatech Pharma plc, Healthcare stocks ...
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS N...
ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 18, 2020 / Midatech Pharma PLC ("Midatech" or the "Company") (AIM:MTPH.L; NASDAQ:MTP), an R&D biotechnology company focused on delivering innovative oncology and rare disease products to patients, is pleased to announce that it has entered into de...
Midatech Pharma (NASDAQ: MTP ): FY net loss of £9.1M More news on: Midatech Pharma plc, Earnings news and commentary, Healthcare stocks news, , Read more ...
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is ...
News, Short Squeeze, Breakout and More Instantly...
Share Consolidation, Change of Name, Adoption of New Articles and Cancellation of Admission to Trading on AIM ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 24, 2023 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodist...
Midatech Pharma PLC ("Midatech" or the "Company") Further re: Notice of General Meeting - Correction of Typographical Errors ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 10, 2023 / Further to the announcement made on 8 March 2023 providing notice of a general meeting (the " GM ") of the Compan...
ABINGDON, UK / ACCESSWIRE / February 15, 2023 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines, announces the closing of the Private Placement of 10,344,822 Units initially at an issue price...